Navigation Links
Non-Medical Use of Prescriptions Linked to Drug Abuse Risk
Date:3/3/2008

Study of college students finds 20% took substances without approval

MONDAY, March 3 (HealthDay News) -- Among college students, non-medical use of frequently abused prescription drugs increases the risk of drug abuse, says a University of Michigan study.

Researcher Sean Esteban McCabe asked 3,639 college students, average age 19.9 years, about their prescribed or non-prescribed use of four classes of prescription drugs -- opioids, stimulants, sleeping aids and sedative or anxiety medications.

The students were also asked about any drug-related problems (such as performing illegal activities to obtain drugs, having withdrawal symptoms, or developing medical problems) that might indicate drug abuse.

The study found that 59.9 percent of the students reported having used at least one of the four kinds of drugs with a prescription for medical reasons, and about 20 percent reported non-prescribed, non-medical use of a drug.

Overall, 1,412 (39.7 percent) said they'd used such drugs only by prescription, 156 (4.4 percent) were never prescribed any of the drugs but had used them anyway, and 563 (15.8 percent) had used some of the drugs both with and without a prescription.

Students who said they'd used medications without a prescription -- whether or not they'd used them for medical reasons -- were more likely to screen positive for drug abuse than those who only used the medications for medical reasons or had never used them, the study found.

There was no difference in the rate of positive screening between students who said they only used the drugs by prescription and those who said they'd never taken the medications.

The study was published in the March issue of the Archives of Pediatrics & Adolescent Medicine.

The findings have important implications for prescribing frequently abused medications to college students, McCabe said in a prepared statement.


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Pharmacists Customize Prescriptions By Patient, Day and Dose with onePAC(TM) Packaging
2. Researchers propose consumers buy yearly drug licenses as new way to pay for prescriptions
3. $7 Brand Name Prescriptions for Low Income and Un-Insured Avoid Prescription Discount Cards!
4. AAPM statement on DEA ruling allowing multiple prescriptions for controlled substances
5. Tendon complications, though rare, linked to statins
6. Breast cancer subtypes linked to survival from secondary brain tumors
7. Drugs used for cancer-associated anemia linked with increased risk of blood clots, death
8. Premature births linked to physical abuse
9. Kidney donor age linked to aortic siffening
10. Gene newly linked to inherited ALS may also play role in common dementia
11. Timely Cancer Diagnosis Linked to Insurance Status
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Non-Medical Use of Prescriptions Linked to Drug Abuse Risk
Non-Medical Use of Prescriptions Linked to Drug Abuse Risk
(Date:1/9/2009)...Inc., Horsham, PA announced that a new Hydrophili...ed to the company,s website that provides a forum ...an go to find the latest developments in device co...d coatings news. , Horsha...rsham, PA announced that a new Hydrophilic Coatin...
(Date:1/9/2009)...nd Peptide, a Massachusetts-based designer and pro... for drug and vaccine discovery organizations worl...mical solutions in the face of the global shortage...trategic usage of new solutions are two leading pe...dges. , Gardner, MA (PRWE...
(Date:1/9/2009)...re/ -- , - New Online Service Provides the ...s at Whatever Age , A new website has been ...esigned specifically to get rid of all examination...AID and it can be found at, http://www.befreefrom...struction, there and then, on how to get rid of ex...
(Date:1/8/2009)...stCall/ - Med-Emerg International Inc. (OTCBB:MDER...of health services, is pleased to announce that it...sly announced plan of arrangement (the "Arrangemen...l meeting of MedEmerg,s shareholders held in Toron...e meeting were in favour of the Arrangement. , Th...
Breaking Medicine News(10 mins):Health News:Blog Launched to Discuss Developments in Hydrophilic Coatings for Medical Devices 2Health News:New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives 2Health News:New Experts Help New England Peptide Combat Global Acetonitrile Shortage; Company Integrating Cost-Effective Chemical Solvent Alternatives 3Health News:Be Free From Exam Nerves 2Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2
...n scientist at the US Department of Energys Oak Na...to determine to what extent there is a connection ...odel allows climatologists to relate extremes of a...year rainfall at two locations or two time periods...
...new study by researchers in National Institutes of...cal signs of dementia increases with the number of.... Among their findings is the observation that th... cerebral infarcts (strokes) is the most common mi...
14th of June is celebrated universally as the World Blood Donor Day was initiated,
...aimed that cod liver oil might help keep depressio...d University Hospital in Bergen, Norway has come ...cod liver oil, omega-3 fatty acids. The research w...habits and health of about 22,000 subjects aged 40...
Other Medicine News:Health News:Indo-American Develops Model Linking Human Activity to Climate Change 2Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:World Blood Donor Day 2
(Date:1/8/2009)... LEUVEN, Belgium, January 9 /PRNewswire-FirstCall/...tudied in the Treatment of,Vitreomacular Adhesion...uronext Brussels: THR), a biotechnology company,f...ascular disease and,cancer, announces today that ...microplasmin for the non-surgical treatment of bac...
(Date:1/8/2009)...ney transplantation to be Quark,s second indicatio...iRNA product candidate , , FREMONT, Calif., Ja...a development-stage pharmaceutical company discove...based therapeutics, today announced that it has in...trial evaluating its systemically administered siR...
(Date:1/8/2009)...Southwestern to Identify and Validate Novel Gene E...h Innovative Gene Expression Platform , , FREMO...Gen Biosystems, Inc. (OTC Bulletin Board: WGBS), a...sion, genotyping, cell biology and stem cell resea...arch collaboration with the University of Texas S...
(Date:1/8/2009)... CHICAGO, Jan. 8 If you are taking...y, you,re not alone. Half of the people taking,pr...he reasons are,varied -- they forget, are busy wi... not to. Noncompliance has been called the Achille...neral Everett Koop commented, "Drugs don,t,work i...
Breaking Medicine Technology:ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 2ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 3ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Good Medicine: Smarter Smartphones for People With Chronic Disease 2Neanderthal bearing teeth 7498 1Neanderthal bearing teeth 7498 2Winter Brings Pet Hazards 7495 1Winter Brings Pet Hazards 7495 2Christopher Reeve Honored as Heroes Hero By CNN 7491 1Christopher Reeve Honored as Heroes Hero By CNN 7491 2Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 1Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 2Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 3Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti CD19 Antibody MDX 1342 968 4
...-Mar 26, 2007 - A study comparing,the formulations...YD) used in V-HeFT I and V-HeFT II, and BiDil, the...frican American Heart Failure,Trial (A-HeFT) demon...he formulations used may explain why V-HeFT I and ...ing mortality. Using,identical amounts of active d...
...2007 /PRNewswire/ -- DiObex,Inc., a privately- he...pment of therapeutics to treat metabolic diseases,...- 902, a novel Cortisol,Synthesis Inhibitor. , In ...cebo-controlled trial, patients with type 2 diabet...ty, pharmacokinetics and,activity of three dose le...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 2Diobex Announces Successful Completion of Phase 2a Trial Of,DIO-902, a Novel Cortisol Synthesis Inhibitor for Type 2 Diabetes 3
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: